Insider Transactions in Q4 2024 at Walgreens Boots Alliance, Inc. (WBA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
16,120
-1.52%
|
$145,080
$9.46 P/Share
|
|
Nov 01
2024
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
167,647
+31.92%
|
-
|
|
Nov 01
2024
|
Timothy C Wentworth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
78,142
-5.68%
|
$703,278
$9.46 P/Share
|
|
Nov 01
2024
|
Timothy C Wentworth Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
762,032
+35.63%
|
-
|
|
Nov 01
2024
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,220
-0.42%
|
$46,980
$9.46 P/Share
|
|
Nov 01
2024
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
243,316
+36.72%
|
-
|
|
Nov 01
2024
|
Beth Amber L. Fabbri Chief Corp. Affairs Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,967
-3.12%
|
$35,703
$9.46 P/Share
|
|
Nov 01
2024
|
Beth Amber L. Fabbri Chief Corp. Affairs Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,193
+36.23%
|
-
|
|
Nov 01
2024
|
Mary Langowksi EVP, President U.S. Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
256,684
+33.07%
|
-
|
|
Nov 01
2024
|
Lanesha Minnix EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
166,310
+31.79%
|
-
|
|
Nov 01
2024
|
Neal J. Sample EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,195
-2.79%
|
$199,755
$9.46 P/Share
|
|
Nov 01
2024
|
Neal J. Sample EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
193,583
+32.51%
|
-
|
|
Nov 01
2024
|
William H Shrank Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,523
+50.0%
|
-
|
|
Nov 01
2024
|
Todd Heckman SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,436
-0.86%
|
$21,924
$9.46 P/Share
|
|
Nov 01
2024
|
Todd Heckman SVP, Global Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
50,802
+34.89%
|
-
|
|
Nov 01
2024
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,135
-1.39%
|
$55,215
$9.46 P/Share
|
|
Nov 01
2024
|
Richard P. Gates SVP, Chief Pharmacy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,182
+31.59%
|
-
|
|
Nov 01
2024
|
Elizabeth Burger EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
147,059
+32.08%
|
-
|
|
Nov 01
2024
|
Thomas E Polen Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,799
+47.29%
|
-
|
|
Nov 01
2024
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,141
+50.0%
|
-
|
|
Nov 01
2024
|
Bryan C Hanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,141
+40.67%
|
-
|
|
Nov 01
2024
|
Stefano Pessina Executive Chairman of Board |
SELL
Payment of exercise price or tax liability
|
Direct |
19,438
-1.3%
|
$174,942
$9.46 P/Share
|
|
Nov 01
2024
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
18,201
-1.87%
|
$163,809
$9.46 P/Share
|
|
Nov 01
2024
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
303,476
+23.78%
|
-
|
|
Oct 23
2024
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
621
-0.78%
|
$5,589
$9.35 P/Share
|
|
Oct 23
2024
|
Richard P. Gates SVP, Chief Pharmacy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+2.58%
|
-
|
|
Oct 23
2024
|
Todd Heckman SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
621
-1.39%
|
$5,589
$9.35 P/Share
|
|
Oct 23
2024
|
Todd Heckman SVP, Global Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+4.54%
|
-
|
|
Oct 23
2024
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
3,191
-1.65%
|
$28,719
$9.35 P/Share
|
|
Oct 23
2024
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
10,602
+5.2%
|
-
|
|
Oct 23
2024
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,331
-0.75%
|
$11,979
$9.35 P/Share
|
|
Oct 23
2024
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,544
+2.5%
|
-
|
|
Oct 23
2024
|
Stefano Pessina Executive Chairman of Board |
BUY
Grant, award, or other acquisition
|
Direct |
374,883
+20.1%
|
-
|
|
Oct 23
2024
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
3,841
-0.57%
|
$34,569
$9.73 P/Share
|
|
Oct 23
2024
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
27,263
+3.89%
|
-
|